>
Fa   |   Ar   |   En
   MYCN-mediated miR-21 overexpression enhances chemo-resistance via targeting CADM1 in tongue cancer  
   
نویسنده Zheng Guopei ,Li Nan ,Jia Xiaoting ,Peng Cong ,Luo Liyun ,Deng Yingen ,Yin Jiang ,Song Ying ,Liu Hao ,Lu Minying ,Zhang Zhijie ,Gu Yixue ,He Zhimin
منبع journal of molecular medicine - 2016 - دوره : 94 - شماره : 10 - صفحه:1129 -1141
چکیده    Chemo-resistance is still a major obstacle in successful cancer treatment. previously, we found that mir-21 (mir-21-5p) was upregulated in drug-resistant tongue cancer (tc) cell line tca8113/pym. however, the mechanisms for mir-21 upregulation and its role in chemo-resistance in tc remain unclear. here, we demonstrated that functional inhibition of mir-21 sensitized tc cells to chemotherapy. in agreement, overexpressed mir-21 enhanced chemo-resistance in tc cells. we found that mir-21 directly targeted cadm1 expression, which was downregulated in drug-resistant tc cells. restored cadm1 expression sensitized tc cells to chemotherapy, but cadm1 knockdown induced chemo-resistance. mechanically, cadm1 interacted with bmi1 to inhibit its nuclear translocation. moreover, mycn which was overexpressed in drug-resistant tc cells directly bound to the mir-21 promoter to upregulated mir-21 expression in tc cells. importantly, the expression levels of mir-21 and cadm1 negatively correlated, but mycn and mir-21 positively correlated in tc tissues. high levels of mir-21 and mycn and low level of cadm1 were associated with poor prognosis in tc patients. in conclusion, our study suggests an important role of the mycn/mir-21/cadm1 axis in chemo-resistance in tc patients and lead to promising prognostic biomarkers and novel treatment strategies to improve the chemotherapeutic efficacy for tc patients.
کلیدواژه Tongue cancer ,miR-21 ,CADM1 ,MYCN ,Drug resistance
آدرس Cancer Center of Guangzhou Medical University, Cancer Research Institute of Guangzhou Medical University; Guangzhou Key Laboratory of “Translational Medicine on Malignant Tumor Treatment”, China, Cancer Center of Guangzhou Medical University, Cancer Research Institute of Guangzhou Medical University; Guangzhou Key Laboratory of “Translational Medicine on Malignant Tumor Treatment”, China, Cancer Center of Guangzhou Medical University, Cancer Research Institute of Guangzhou Medical University; Guangzhou Key Laboratory of “Translational Medicine on Malignant Tumor Treatment”, China, Cancer Center of Guangzhou Medical University, Cancer Research Institute of Guangzhou Medical University; Guangzhou Key Laboratory of “Translational Medicine on Malignant Tumor Treatment”, China, Cancer Center of Guangzhou Medical University, Cancer Research Institute of Guangzhou Medical University; Guangzhou Key Laboratory of “Translational Medicine on Malignant Tumor Treatment”, China, Cancer Center of Guangzhou Medical University, Cancer Research Institute of Guangzhou Medical University; Guangzhou Key Laboratory of “Translational Medicine on Malignant Tumor Treatment”, China, Cancer Center of Guangzhou Medical University, Cancer Research Institute of Guangzhou Medical University; Guangzhou Key Laboratory of “Translational Medicine on Malignant Tumor Treatment”, China, Cancer Center of Guangzhou Medical University, Cancer Research Institute of Guangzhou Medical University; Guangzhou Key Laboratory of “Translational Medicine on Malignant Tumor Treatment”, China, Cancer Center of Guangzhou Medical University, Cancer Research Institute of Guangzhou Medical University; Guangzhou Key Laboratory of “Translational Medicine on Malignant Tumor Treatment”, China, Cancer Center of Guangzhou Medical University, Cancer Research Institute of Guangzhou Medical University; Guangzhou Key Laboratory of “Translational Medicine on Malignant Tumor Treatment”, China, Cancer Center of Guangzhou Medical University, Cancer Research Institute of Guangzhou Medical University; Guangzhou Key Laboratory of “Translational Medicine on Malignant Tumor Treatment”, China, Cancer Center of Guangzhou Medical University, Cancer Research Institute of Guangzhou Medical University; Guangzhou Key Laboratory of “Translational Medicine on Malignant Tumor Treatment”, China, Cancer Center of Guangzhou Medical University, Cancer Research Institute of Guangzhou Medical University; Guangzhou Key Laboratory of “Translational Medicine on Malignant Tumor Treatment”, China
 
     
   
Authors
  
 
 

Copyright 2023
Islamic World Science Citation Center
All Rights Reserved